Open access
Aug 2026
Therapeutic potential of a novel PPARγ agonist in a mouse model of HIV-associated neurocognitive impairment.
PPARγ could serve as a novel molecular target for the treatment of HIV-associated NCI, with INT131 identified as a promising therapeutic candidate.
Celene Titus, M. T. Hoque, Robert P. Bonin et al.
· Brain, behavior, and immunit... · 0 citations